Peptide Research News - Pangaea Ventures Leads Vestaron's $10.2 Million Series B Financing - TechFinance

Pangaea Ventures Leads Vestaron's $10.2 Million Series B Financing - TechFinance

Pangaea Ventures Leads Vestaron's $10.2 Million Series B Financing TechFinance Vestaron Corporation, a developer of insecticides using natural peptides from spiders, has raised $10.2 million in Series B funding led by a new investor, Vancouver based Pangaea Ventures. New investors, Michigan Accelerator Fund, and two private ... Vestaron Raises $10.2 Million From Series B Preferred Stock FinancingMarketWatch (press release) all 7 news articles »

Click Here to read the entire article...